MELVILLE, NY--(Marketwire - February 22, 2011) - FONAR Corporation (NASDAQ: FONR) today announced its financial results for the second quarter of fiscal 2011, which ended December 31, 2010. During the quarter, net income and also income from operations, was $1.4 million. This compares to the second quarter of fiscal 2010, which ended December 31, 2009, when the net loss and also the loss from operations was $1.3 million. The Company has had three consecutive quarters of positive net income, and four consecutive quarters of positive income from operations.
A graph of the Net (Loss) Income for the past six quarters can be found at: www.fonar.com/news/022211.htm
For the first six months of fiscal 2011, which ended December 31, 2010, net income was $1.9 million as compared to a net loss of $2.7 million, one year earlier, for the six month period which ended December 31, 2009.
Total revenues for the second quarter of fiscal 2011 ended December 31, 2010, were $8.0 million as compared to $8.2 million for the same period last year which ended December 31, 2009. Total revenues for the six months ended December 31, 2010 were $16.7 million as compared to $15.7 million for the same period last year.
During the second quarter of fiscal 2011 for the period ended December 31, 2010, total product sales were $1.8 million, versus $3.0 million for the same period last year. Total service and repair net fees for the second fiscal quarter of 2011 for the period ended December 31, 2010 were $2.7 million versus $2.7 million for the same period last year. Management & other fees were at $3.5 million during the second quarter of fiscal 2011 for the period ended December 31, 2010 as compared to $2.6 million for the same period last year. As of December 31, 2010, FONAR had installed 149 UPRIGHT® Multi-Position™ MRI units worldwide.
As of December 31, 2010, total cash, cash equivalents and marketable securities were approximately $2.0 million, an approximate 50% increase from $1.3 million as of June 30, 2010. Total current assets were $15.2 million, total assets were $24.1 million, total current liabilities were $24.9 million, and total long-term liabilities were $2.8 million.
NASDAQ Continued Listing
On October 14, 2010, the Company received notice from the NASDAQ Listing Qualifications Staff that based upon the Company’s non-compliance with the $2.5 million stockholders’ equity requirement set forth in NASDAQ Listing Rule 5550(b), the Company’s securities were subject to delisting from The NASDAQ Capital Market. One day earlier, on October 13, 2010, the Company had reported its 10-K for the period ended June 30, 2010. The Company also did not meet the alternative requirements of $35 million in market capitalization for its listed securities (FONR), or net income from continuing operations of $500,000. Pursuant to the Listing Rules, the Company requested and was granted an extension, through January 7, 2011, to submit a plan of compliance. Subsequently, on January 11, 2011, the Company received a determination letter from the Listing Qualifications Staff of The NASDAQ Stock Market LLC (the “Staff Determination”) notifying the Company that, unless the Company requests a hearing before the NASDAQ Listing Qualifications Panel (the “NASDAQ Panel”), that the Company’s securities would be delisted.
The Company has requested a hearing before the NASDAQ Panel, which will stay any action with respect to the Staff Determination until the Panel renders a decision subsequent to the hearing. The hearing will be held on February 24, 2011. There can be no assurance that the Panel will grant the Company’s appeal for continued listing.
Raymond Damadian, president and founder of FONAR, said, “Hard work, difficult cut-backs and an outstanding product, the FONAR UPRIGHT® Multi-Position™ MRI are behind our record-setting quarterly net income of $1,363,000. The cut-backs have been particularly hard but have been offset by the enthusiasm in our recently enacted business strategy, which capitalizes on the scanning center management business. At each of the scanning centers that we manage, our UPRIGHT® Multi-Position™ MRI scanners had more patient throughput during the second quarter of fiscal 2011 than were scanned in the second quarter of fiscal 2010.”
FONAR CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (000’s OMITTED) ASSETS December 31, June 30, 2010 2010 (UNAUDITED) Current Assets: --------- --------- Cash and cash equivalents $ 1,961 $ 1,299 Marketable securities 33 28 Accounts receivable - net 5,390 4,821 Accounts receivable - related parties - net 118 - Medical receivables - net 4 25 Management fee receivable - net 2,428 2,569 Management fee receivable - related medical practices - net 1,751 1,922 Costs and estimated earnings in excess of billings on uncompleted contracts 273 277 Inventories 2,757 2,826 Advances and notes to related medical practices - net - 83 Current portion of notes receivable 190 272 Prepaid expenses and other current assets 294 553 --------- --------- Total Current Assets 15,199 14,675 --------- --------- Property and equipment - net 3,827 2,109 Notes receivable - net 238 - Other intangible assets - net 4,137 4,291 Other assets 673 554 --------- --------- Total Assets $ 24,074 $ 21,629 ========= ========= FONAR CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (000’s OMITTED) December 31, June 30, LIABILITIES AND STOCKHOLDERS’ DEFICIENCY 2010 2010 (UNAUDITED) Current Liabilities: ----------- --------- Current portion of long-term debt and capital leases $ 2,231 $ 579 Current portion of long-term debt-related party - 88 Accounts payable 2,425 3,192 Other current liabilities 8,683 8,065 Unearned revenue on service contracts 5,834 5,220 Unearned revenue on service contracts - related parties 110 - Customer advances 4,450 4,813 Billings in excess of costs and estimated earnings on uncompleted contracts 1,132 2,743 --------- --------- Total Current Liabilities 24,865 24,700 Long-Term Liabilities: Accounts payable 135 63 Due to related medical practices 231 528 Long-term debt and capital leases, less current portion 1,906 1,567 Long-term debt less current portion-related party - 72 Other liabilities 494 475 --------- --------- Total Long-Term Liabilities 2,766 2,705 --------- --------- Total Liabilities 27,631 27,405 --------- --------- FONAR CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (000’s OMITTED, except share data) December 31, June 30, LIABILITIES AND STOCKHOLDERS’ DEFICIENCY 2010 2010 (continued) (UNAUDITED) ----------- -------- STOCKHOLDERS’ DEFICIENCY: Class A non-voting preferred stock $.0001 par value; 453,000 and 1,600,000 shares authorized at December 31, 2010 and June 30, 2010, respectively; 313,451 issued and outstanding at December 31, 2010 and June 30, 2010 - - Preferred stock $.001 par value; 567,000 and 2,000,000 shares authorized at December 31, 2010 and June 30, 2010, respectively; issued and outstanding - none - - Common Stock $.0001 par value; 8,500,000 and 30,000,000 shares authorized at December 31, 2010 and June 30, 2010, respectively; 5,241,358 and 4,985,850 issued at December 31, 2010 and June 30, 2010, respectively; 5,229,715 and 4,974,207 outstanding at December 31, 2010 and June 30, 2010, respectively 1 1 Class B Common Stock $ .0001 par value; 227,000 and 800,000 shares authorized at December 31, 2010 and June 30, 2010, respectively; (10 votes per share), 158 issued and outstanding at December 31, 2010 and June 30, 2010 - - Class C Common Stock $.0001 par value; 567,000 and 2,000,000 shares authorized at December 31, 2010 and June 30, 2010, respectively; (25 votes per share), 382,513 issued and outstanding at December 31, 2010 and June 30, 2010 - - Paid-in capital in excess of par value 172,773 172,379 Accumulated other comprehensive loss (14) (19) Accumulated deficit (175,523) (177,271) Notes receivable from employee stockholders (119) (191) Treasury stock, at cost - 11,643 shares of common stock At December 31, 2010 and June 30, 2010 (675) (675) --------- -------- Total Stockholders’ Deficiency (3,557) (5,776) --------- -------- Total Liabilities and Stockholders’ Deficiency $ 24,074 $ 21,629 ========= ======== FONAR CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (000’s OMITTED, except per share data) FOR THE THREE MONTHS ENDED DECEMBER 31, -------------------- 2010 2009 REVENUES --------- --------- Product sales - net $ 1,789 $ 2,961 Service and repair fees - net 2,653 2,629 Service and repair fees - related parties - net 55 55 Management and other fees - net 2,380 1,738 Management and other fees - related medical practices - net 1,142 830 --------- --------- Total Revenues - Net 8,019 8,213 --------- --------- COSTS AND EXPENSES Costs related to product sales 1,368 2,279 Costs related to service and repair fees 700 978 Costs related to service and repair fees - related parties 15 20 Costs related to management and other fees 1,707 1,384 Costs related to management and other fees - related medical practices 633 745 Research and development 153 777 Selling, general and administrative 1,745 3,100 Provision for bad debts 255 197 --------- --------- Total Costs and Expenses 6,576 9,480 --------- --------- Income (Loss) From Operations 1,443 (1,267) Interest Expense (137) (90) Interest Expense - Related Party - (5) Investment Income 58 66 Interest Income - Related Party - 3 Other (Expense) Income (1) 1 --------- --------- NET INCOME (LOSS) $ 1,363 $ (1,292) ========= ========= NET INCOME AVAILABLE TO CLASS C COMMON STOCKHOLDERS $ 25 $ N/A ========= ========= Net Income (Loss) Available to Common Stockholders $ 1,261 $ (1,292) ========= ========= Basic Net Income (Loss) Per Common Share $ 0.25 $ (0.26) ========= ========= Diluted Net Income (Loss) Per Common Share $ 0.24 $ (0.26) ========= ========= Basic and Diluted Income Per Share-Common C $ 0.06 N/A ========= ========= Weighted Average Basis Shares Outstanding 5,149,499 4,916,275 ========= ========= Weighted Average Diluted Shares Outstanding 5,277,003 4,916,275 ========= ========= FONAR CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (000’s OMITTED, except per share data) FOR THE SIX MONTHS ENDED DECEMBER 31, -------------------- 2010 2009 REVENUES --------- --------- Product sales - net $ 4,448 $ 4,524 Service and repair fees - net 5,342 5,386 Service and repair fees - related parties - net 110 110 Management and other fees - net 4,469 3,473 Management and other fees - related medical practices - net 2,335 1,625 License fees and royalties - 585 --------- --------- Total Revenues - Net 16,704 15,703 --------- --------- COSTS AND EXPENSES Costs related to product sales 3,873 3,936 Costs related to service and repair fees 1,366 1,919 Costs related to service and repair fees - related parties 28 39 Costs related to management and other fees 3,021 2,651 Costs related to management and other fees - related medical practices 1,372 1,505 Research and development 607 1,631 Selling, general and administrative 4,128 6,333 Provision for bad debts 431 377 --------- --------- Total Costs and Expenses 14,826 18,391 --------- --------- Income (Loss) From Operations 1,878 (2,688) Interest Expense (231) (169) Interest Expense - Related Party (4) (19) Investment Income 96 153 Interest Income - Related Party 1 6 Other Income 8 34 Loss on Note Receivable - (350) --------- --------- NET INCOME (LOSS) $ 1,748 $ (3,033) ========= ========= NET INCOME AVAILABLE TO CLASS C COMMON STOCKHOLDERS $ 32 $ N/A ========= ========= Net Income (Loss) Available to Common Stockholders $ 1,618 $ (3,033) ========= ========= Basic Net Income (Loss) Per Common Share $ 0.32 $ (0.62) ========= ========= Diluted Net Income (Loss) Per Common Share $ 0.31 $ (0.62) ========= ========= Basic and Diluted Income Per Share-Common C $ 0.08 N/A ========= ========= Weighted Average Basic Shares Outstanding 5,080,872 4,912,108 ========= ========= Weighted Average Diluted Shares Outstanding 5,208,376 4,912,108 ========= =========
For investor and other information visit: www.fonar.com.
UPRIGHT® and STAND-UP® are registered trademarks and The Inventor of MR Scanning™, Full Range of Motion™, pMRI™, Dynamic™, Multi- Position™, True Flow™, The Proof is in the Picture™, Spondylography™ Spondylometry™ and Upright Radiology™ are trademarks of FONAR Corporation.
This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company’s financial results may be found in the company’s filings with the Securities and Exchange Commission.
Contact:
Daniel Culver
FONAR Corporation
Tel: 631-694-2929
Fax: 631-390-1709
http://www.fonar.com
Email Contact
